Drug Sponsors

Amneal launches new biosciences unit

Thursday, August 27, 2015

Amneal Pharmaceuticals has launched Amneal Biosciences, a wholly owned subsidiary. Amneal Biosciences will focus exclusively on the commercialization of high-barrier-to-entry generic and specialty pharmaceuticals such as injectables, oncologics and biosimilars to healthcare providers globally.

[Read More]

Royal DSM reorganizes; 1,000 jobs cut

Wednesday, August 26, 2015

Royal DSM, a global life sciences and materials sciences company, has made adjustments to its organizational and operating model, including a reduction in headcount of 900 to 1,100, half of which will occur in the Netherlands. Those cuts will be fully implemented by the end of 2017.

[Read More]